- Recent Funding
- Investors
- Atlas Venture
Atlas Venture portfolio
Atlas Venture has 5 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months. It is a venture capital firm based in Cambridge, US, founded in 1993. It led 2 of the 7 rounds it joined. Its most recent investment on record is Matchpoint Therapeutics's $150M Series B+ round in October 2026, alongside T1D Fund, Sanofi Ventures, Norwest Venture Partners and 6 others. By category, its portfolio leans toward Health and bio (5) and Education (1). It has co-invested with Access Biotechnology, Gimv and Sofinnova Partners, most often Access Biotechnology (2 rounds).
About Atlas Venture
Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Funds raised
| Fund | Fund # | Size | Announced |
|---|---|---|---|
| III | $400M | Pulse 2.0 | |
| XIV | $450M | Business Wire |
Venture funds Atlas Venture raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.
What Atlas Venture invests in
- Health and bio · 5 · 100%
- Education · 1 · 20%
- Legal and compliance · 1 · 20%
- Data and analytics · 1 · 20%
- Consumer and social · 1 · 20%
Atlas Venture recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $150M | T1D Fund, Sanofi Ventures, Norwest Venture Partners (lead) +6 | ||
| Series B+ · $103M | Willett Advisors LLC, Vivo Capital, Sixty Degree Capital +6 | ||
| Series A · $40M · lead | Gimv, 5AM Ventures (lead) | ||
| Series B+ · $65M | Tekla Capital Management, SR One (lead), Solasta Ventures +3 | ||
| Series A · $50M | Novo Holdings (lead), Foresite Capital, Access Biotechnology | ||
| Series A · $45M · lead | Sofinnova Partners (lead) | ||
| Series A · $6M | Valley Oak Investments, Promus Ventures, NextView Ventures +4 |
How Atlas Venture invests
Share is of the 7 rounds on Recent Funding that name Atlas Venture. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Atlas Venture portfolio companies
MMatchpoint Therapeutics$150MSeries B+ · Oct 2026
KKinaset Therapeutics$103MSeries B+ · Jan 2026
HHotSpot Therapeutics$65MSeries B+ · May 2020
DDisc Medicine$50MSeries A · Oct 2019
WWHOOP$6MSeries A · Jun 2014
| Company | Round with Atlas Venture | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $150M | $250M | Oct 7, 2026 Series B+ |
Health and bio |
Series B+ · $103M | $143M | Jan 9, 2026 Series B+ |
Legal and compliance |
Series B+ · $65M | $210M | Nov 29, 2021 Series B+ |
Health and bio |
Series A · $50M | $140M | Sep 2, 2021 Series B+ |
Health and bio |
Series A · $6M | $973M | Jun 5, 2026 Series B+ |
Most frequent co-investors
AAccess Biotechnology2 shared rounds · last Oct 7, 2026
GGimv2 shared rounds · last Jan 9, 2026
SSofinnova Partners2 shared rounds · last May 21, 2020
NNorwest Venture Partners1 shared round · last Oct 7, 2026
SSanofi Ventures1 shared round · last Oct 7, 2026
IInvus1 shared round · last Oct 7, 2026
DDigitalis Ventures1 shared round · last Oct 7, 2026
TT1D Fund1 shared round · last Oct 7, 2026
NNextech Invest1 shared round · last Oct 7, 2026
BBOLD Longevity Growth Fund1 shared round · last Oct 7, 2026
BBB Biotech1 shared round · last Oct 7, 2026
SSchroders Capital1 shared round · last Jan 9, 2026
Similar investors
MMaverick Ventures5 companies · 3 deals in 12 moRRegeneron Ventures5 companies · 3 deals in 12 mo
TThe Venture Collective5 companies · 3 deals in 12 mo
BBayern Kapital5 companies · 2 deals in 12 mo
FFlare Capital Partners5 companies · 2 deals in 12 mo
MMarshall Wace5 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Atlas Venture, which is a subset of its real portfolio. API: /api/v1/investors/atlas-venture (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy